Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03330522 · ClinicalTrials.gov registry record · NA
Reducing HIV Risk in Urban Women: Soap Opera Videos on Video-Capable Cell Phones
A NA study, sponsored by Northeastern University.
- Completed
- Registry status
- NA
- Development phase
- 295
- Enrollment target
NCT03330522: Completed NA study, sponsored by Northeastern University.
NCT03330522 is a NA study that has completed, run by Northeastern University. The registered enrollment target is 295 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03330522, a NA study, has completed, sponsored by Northeastern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 295 participants
- Enrollment target
Study Summary
Background: Love, Sex, and Choices (LSC) is a soap opera video series created to reduce HIV sex risk in women. Methods: LSC was compared to text messages in a randomized trial in 238 high-risk mostly Black young urban women. 117 received 12-weekly LSC videos, 121 received 12-weekly HIV prevention messages on smartphones. Changes in unprotected sex with high risk partners were compared by mixed models.
Primary Outcome
Sex risk is measured by the Vaginal Episode Equivalent (VEE) score (Susser, Desvarieux, \& Wittkowski, 1998) with high risk partners. The VEE is the sum of all unprotected vaginal anal sex acts weighted by the relative HIV transmission risk (vaginal 1 and anal 2). A high risk partner is defined as the likelihood the male partner had sex with another woman, sex with men, or injected drugs in the past 3 months. Partner risk could range from 0 to 9; main or non-main partners with scores \> 0 were c
Interventions
- OTHER Love, Sex, & Choices video series
- OTHER Messages in text
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 295 participants |
| Start Date | 2008-11-26 |
| Est. Completion | 2014-02-28 |
| Phase | NA |
What the finished NCT03330522 record still lists
NCT03330522 is an interventional study that assigns participants to a tested intervention. The registered 295 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Love, Sex, & Choices video series is the first listed.
NCT03330522 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03330522 about?
NCT03330522 is a clinical study titled "Reducing HIV Risk in Urban Women: Soap Opera Videos on Video-Capable Cell Phones". Background: Love, Sex, and Choices (LSC) is a soap opera video series created to reduce HIV sex risk in women. Methods: LSC was compared to text messages in a randomized trial in 238 high-risk mostly Black young urban women. 117 received 12-weekly LSC videos, 121 received 12-weekly HIV prevention m...
What is the current status of trial NCT03330522?
This trial is currently completed. It is a NA study. The enrollment target is 295 participants. The study started on 2008-11-26. Estimated completion is 2014-02-28.
What interventions are being tested in trial NCT03330522?
The interventions under investigation include: Love, Sex, & Choices video series (OTHER), Messages in text (OTHER).
Who is sponsoring clinical trial NCT03330522?
This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03330522's enrollment target sits among peer trials
295 373rd of 2000 higher than 1,628 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05201781 · 295 participants · Phase 4
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- NCT06004245 · 295 participants · Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
- NCT06494111 · 295 participants · Phase 2
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
- NCT07020221 · 295 participants · Phase 1
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI